227 related articles for article (PubMed ID: 25290417)
1. Immunoglobulin replacement therapy for primary immunodeficiencies.
Peter JG; Chapel H
Immunotherapy; 2014; 6(7):853-69. PubMed ID: 25290417
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin Replacement Therapy for Primary Immunodeficiency.
Sriaroon P; Ballow M
Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315
[TBL] [Abstract][Full Text] [Related]
3. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
Pac M
Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU
Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin treatment in primary antibody deficiency.
Maarschalk-Ellerbroek LJ; Hoepelman IM; Ellerbroek PM
Int J Antimicrob Agents; 2011 May; 37(5):396-404. PubMed ID: 21276714
[TBL] [Abstract][Full Text] [Related]
6. The Nuts and Bolts of Immunoglobulin Treatment for Antibody Deficiency.
Wasserman RL
J Allergy Clin Immunol Pract; 2016; 4(6):1076-1081.e3. PubMed ID: 27836057
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance.
Högy B; Keinecke HO; Borte M
Eur J Health Econ; 2005 Mar; 6(1):24-9. PubMed ID: 15480920
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous immunoglobulin replacement therapy: the European experience.
Chapel H; Gardulf A
Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):623-9. PubMed ID: 24126615
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland.
Pac M; Bernatowska E
Eur J Pediatr; 2016 Aug; 175(8):1099-105. PubMed ID: 27357411
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies.
Borte M; Bernatowska E; Ochs HD; Roifman CM;
Clin Exp Immunol; 2011 Jun; 164(3):357-64. PubMed ID: 21413943
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomics of immunoglobulins in primary immunodeficiency.
Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):375-86. PubMed ID: 19670998
[TBL] [Abstract][Full Text] [Related]
12. Facilitated subcutaneous immunoglobulin (fSCIg) therapy--practical considerations.
Ponsford M; Carne E; Kingdon C; Joyce C; Price C; Williams C; El-Shanawany T; Williams P; Jolles S
Clin Exp Immunol; 2015 Dec; 182(3):302-13. PubMed ID: 26288095
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin: a review.
Eibl MM; Wedgwood RJ
Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
[TBL] [Abstract][Full Text] [Related]
14. Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?
Abolhassani H; Asgardoon MH; Rezaei N; Hammarstrom L; Aghamohammadi A
Expert Rev Clin Immunol; 2015; 11(11):1229-43. PubMed ID: 26289377
[TBL] [Abstract][Full Text] [Related]
15. Human immunoglobulin 10 % with recombinant human hyaluronidase: replacement therapy in patients with primary immunodeficiency disorders.
Sanford M
BioDrugs; 2014 Aug; 28(4):411-20. PubMed ID: 24925799
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous immunoglobulin replacement therapy with Hizentra, the first 20% SCIG preparation: a practical approach.
Jolles S; Sleasman JW
Adv Ther; 2011 Jul; 28(7):521-33. PubMed ID: 21681653
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous immunoglobulin replacement in primary immunodeficiencies.
Berger M
Clin Immunol; 2004 Jul; 112(1):1-7. PubMed ID: 15207776
[TBL] [Abstract][Full Text] [Related]
18. [Subcutaneous immunoglobulin substitution and therapy].
Gulácsy V; Maródi L
Orv Hetil; 2011 Jan; 152(2):64-7. PubMed ID: 21177233
[TBL] [Abstract][Full Text] [Related]
19. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.
Jolles S; Orange JS; Gardulf A; Stein MR; Shapiro R; Borte M; Berger M
Clin Exp Immunol; 2015 Feb; 179(2):146-60. PubMed ID: 25384609
[TBL] [Abstract][Full Text] [Related]
20. Nursing guidelines for administration of immunoglobulin replacement therapy.
Younger ME; Aro L; Blouin W; Duff C; Epland KB; Murphy E; Sedlak D;
J Infus Nurs; 2013; 36(1):58-68. PubMed ID: 23271153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
